Ask most people what recovery looks like, and they'll describe the same finish line: total abstinence. And they're not wrong to. Abstinence is the safest path, the only way to fully sidestep the physical, mental, and social toll that substance use can take (Marlatt, 1998). A body and mind given the chance to heal without the influence of illicit substances will, in most cases, heal better.
But almost nobody gets there in a straight line. Recovery is messy. People slip, stall, circle back, and try again, often more than once. If the only door we open is the one marked "100% ready to quit today," we lose a lot of people who simply aren't there yet, and may never get there if no one meets them halfway. That's the gap harm reduction fills, and it's become one of the most valuable tools in my practice.
So what is harm reduction, exactly?
At its core, harm reduction is a collection of strategies for lowering the risks that come with substance use, without requiring someone to stop using as a condition of getting help. It starts from a simple premise: people deserve support and dignity right now, not just once they hit some threshold of readiness.
I still hear the same worry from time to time: doesn't this just enable people to keep using? The research says otherwise, and it says so pretty clearly.
Take overdose prevention. Naloxone, the medication that can reverse an opioid overdose in minutes, saves lives when people have access to it and know how to use it. With overdose deaths in the U.S. topping 100,000 a year in recent years, that kind of immediate intervention isn't optional anymore; it's essential (Spencer et al., 2024). And the fear that wider naloxone access might encourage more drug use just hasn't held up. Communities with better access see fewer deaths, not more use (Smart et al., 2021).
The same logic holds for syringe access programs. Clean equipment means fewer new HIV and Hepatitis C infections, and it keeps people safer during the exact period when they're still using (Hagan et al., 2000). It's not a workaround to treatment; it's what keeps someone alive and healthy enough to eventually consider it.
And that's maybe the part people underestimate most: harm reduction often becomes the bridge to treatment, not a detour from it. When someone is met with respect instead of judgment, they're far more willing to come back, ask questions, and eventually take the next step. People who engage with harm reduction services are up to five times more likely to enter formal treatment down the line than those who never engage at all (Recovery Research Institute, 2023).
Abstinence and harm reduction don't have to compete for the same lane. They work better together than either does alone. Harm reduction is what keeps someone alive, safe, and in touch with people who can help, long enough for them to find their own reasons to pursue abstinence, on their own timeline.
Every step in the right direction counts. Using a clean syringe. Carrying naloxone. Cutting back, even a little. Finally asking for help after months of not being ready to. None of that is small. Recovery was never about being perfect. It's about moving forward, one honest step at a time. If you're struggling today, please hear this: your life has value, and there is support out there to help you stay safe.
References
Hagan, H., McGough, J. P., Thiede, H., Weiss, N. S., Hopkins, S., & Alexander, E. R. (2000). Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment, 19(3), 247–252.
Marlatt, G. A. (1998). Basic principles and strategies of harm reduction. In G. A. Marlatt (Ed.), Harm reduction: Pragmatic strategies for managing high-risk behaviors (pp. 49–66). Guilford Press.
Recovery Research Institute. (2023). Harm reduction: Policies, programs, and practices. Massachusetts General Hospital. https://www.recoveryanswers.org/resource/drug-and-alcohol-harm-reduction/
Smart, R., Pardo, B., & Davis, C. S. (2021). Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States. Addiction, 116(1), 6–17. https://doi.org/10.1111/add.15163
Spencer, M. R., Garnett, M. F., & Miniño, M. (2024). Drug overdose deaths in the United States, 2002-2022. NCHS Data Brief, No. 491. Centers for Disease Control and Prevention.
Photo by Austin Kehmeier on Unsplash
Comments ()